市場調査レポート
商品コード
1559165

RNAシーケンシング:各種技術と世界市場

RNA Sequencing: Technologies and Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 166 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.02円
RNAシーケンシング:各種技術と世界市場
出版日: 2024年09月20日
発行: BCC Research
ページ情報: 英文 166 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のRNAシーケンシングの市場規模は、2024年の43億米ドルから、予測期間中はCAGR 19.1%で推移し、2029年末には103億米ドルの規模に達すると予測されています。

ツール・試薬の部門は、2024年の30億米ドルから、CAGR 19.6%で推移し、2029年末には74億米ドルに達すると予測されています。また、機器の部門は、2024年の6億4,560万米ドルから、CAGR 18.2%で推移し、2029年末には15億米ドルに達すると予測されています。

当レポートでは、世界のRNAシーケンシングの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

  • 市場見通し
  • 調査範囲
  • 市場概要

第2章 市場概要

  • 概要
  • 技術背景
  • トランスクリプトミクス技術
  • トランスクリプトミクスのためのRNAシーケンシング
  • RNA-Seqの実験的ワークフロー
  • RNA-Seqワークフローの考慮事項
  • RNAシーケンシングに適したプラットフォームを選択する手順
  • 規制状況
  • 成長戦略の提案

第3章 市場力学

  • 市場力学
  • 市場促進要因
  • データ分析能力の急速な進歩
  • ゲノミクスとバイオ医療研究に対する好ましい資金調達シナリオ
  • ゲノムシークエンシングの価格低下
  • がん罹患率の増加による個別化治療の需要の増加
  • 市場抑制要因
  • データ標準化の欠如
  • コストとカバレッジの課題
  • 市場機会
  • ブロックチェーンとクラウドコンピューティング技術の活用
  • RNAの分離と抽出プロセスにおける技術的進歩

第4章 新興技術と開発

  • 単一細胞RNAシーケンシング
  • その他の新しい単一細胞技術

第5章 市場セグメンテーション分析

  • 主な市場動向
  • セグメンテーションの内訳
  • 世界のRNAシーケンシング市場:製品別
  • 機器
  • ツール・試薬
  • ソフトウェア・サービス
  • 世界のRNAシーケンシング市場:技術別
  • 合成による配列決定
  • イオントレント半導体シーケンシング
  • 単一分子リアルタイムシーケンシング
  • ナノポアシーケンシング
  • 世界のRNAシーケンシング市場:用途別
  • 発現プロファイリング解析
  • small RNAシーケンシング
  • De Novoトランスクリプトームアセンブリ
  • バリアントコールとトランスクリプトームエピジェネティクス
  • 世界のRNAシーケンシング市場:エンドユーザー別
  • 学術研究機関
  • 製薬・バイオテクノロジー企業
  • 臨床ラボ・病院ラボ
  • その他
  • 地理的内訳
  • 世界のRNAシーケンシング市場:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第6章 競合情報

  • 概要
  • 主要企業のランキング
  • 企業の採用戦略
  • コラボレーションと契約
  • 新製品の発売
  • パートナーシップ
  • 拡張
  • M&A
  • RNAシーケンシングのデータ生成におけるCROの役割
  • 大手RNAシーケンシングサービスプロバイダー

第7章 RNAシーケンシング市場における持続可能性:ESGの観点

  • ESG:イントロダクション
  • 市場におけるESGパフォーマンス
  • RNAシーケンシング業界におけるESGの実践
  • 環境パフォーマンス
  • 社会的パフォーマンス
  • ガバナンスパフォーマンス
  • BCCによる総論

第8章 付録

  • 調査手法
  • 参考文献
  • 頭字語
  • 企業プロファイル
  • 10X GENOMICS
  • AGILENT TECHNOLOGIES INC.
  • BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
  • BIO-RAD LABORATORIES INC.
  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA INC.
  • INTEGRATED DNA TECHNOLOGIES INC.
  • MICROSYNTH AG
  • OXFORD NANOPORE TECHNOLOGIES PLC.
  • QIAGEN
  • REVVITY
  • STANDARD BIOTOOLS
  • THERMO FISHER SCIENTIFIC INC.
図表

List of Tables

  • Summary Table A : Global Market for RNA Sequencing, by Product, Through 2029
  • Summary Table B : Global Market for RNA Sequencing, by Technology, Through 2029
  • Table 1 : Types of RNAs in Cells
  • Table 2 : Comparison of Transcriptomics Methods
  • Table 3 : Functional Elements in Sequencing Adapters
  • Table 4 : Publicly Available Transcriptomics Data in the Cancer Research Field
  • Table 5 : Overview of Illumina's Sequencing Instruments
  • Table 6 : Global Market for RNA Sequencing for Instruments, by Region, Through 2029
  • Table 7 : Global Market for RNA Sequencing for Tools and Reagents, by Region, Through 2029
  • Table 8 : rRNA Depletion Kits
  • Table 9 : mRNA Enrichment Kits
  • Table 10 : Global Market for RNA Sequencing Sample Preparation for Tools & Reagents, by Region, Through 2029
  • Table 11 : RNA Sequencing Kits for Illumina Platform
  • Table 12 : Thermo Fisher RNA Sequencing Products for Ion Torrent
  • Table 13 : Thermo Fisher's RNA Sequencing Library Prep Kits for SOLiD
  • Table 14 : Global Market for RNA Sequencing Library Preparation for Tools and Reagents, by Region, Through 2029
  • Table 15 : Cloud Computing Providers for Genomics/RNA-Seq
  • Table 16 : Global Market for RNA Sequencing for Software and Services, by Region, Through 2029
  • Table 17 : RNA Sequencing Applications on Illumina Platforms
  • Table 18 : Global Market for RNA Sequencing for Sequencing by Synthesis, by Region, Through 2029
  • Table 19 : RNA Sequencing Applications on Ion Torrent Systems
  • Table 20 : Global Market for RNA Sequencing for Ion Torrent Semiconductor, by Region, Through 2029
  • Table 21 : PacBio RNA-Seq Applications
  • Table 22 : PacBio RNA-Seq Workflow
  • Table 23 : Global Market for RNA Sequencing for Single-Molecule Real-Time Sequencing, by Region, Through 2029
  • Table 24 : Global Market for RNA Sequencing for Nanopore Sequencing, by Region, Through 2029
  • Table 25 : Global Market for RNA Sequencing for Expression Profiling Analysis, by Region, Through 2029
  • Table 26 : Small RNA-Seq on Illumina Platforms
  • Table 27 : Global Market for RNA Sequencing for Small RNA Sequencing, by Region, Through 2029
  • Table 28 : Global Market for RNA Sequencing for De Novo Transcriptome Assembly, by Region, Through 2029
  • Table 29 : Global Market for RNA Sequencing for Variant Calling & Transcriptome Epigenetics, by Region, Through 2029
  • Table 30 : Global Market for RNA Sequencing for Academic Research Organizations, by Region, Through 2029
  • Table 31 : Global Market for RNA Sequencing for Pharmaceutical and Biotechnology Companies, by Region, Through 2029
  • Table 32 : Global Market for RNA Sequencing for Clinical and Hospital Laboratories, by Region, Through 2029
  • Table 33 : Global Market for RNA Sequencing for Other End Users, by Region, Through 2029
  • Table 34 : Global Market for RNA Sequencing, by Region, Through 2029
  • Table 35 : North American Market for RNA Sequencing, by Product, Through 2029
  • Table 36 : North American Market for RNA Sequencing for Tools & Reagents, by Type, Through 2029
  • Table 37 : North American Market for RNA Sequencing, by Technology, Through 2029
  • Table 38 : North American Market for RNA Sequencing, by Application, Through 2029
  • Table 39 : North American Market for RNA Sequencing, by End User, Through 2029
  • Table 40 : Research Initiatives Focused on Personalized Medicine in Europe
  • Table 41 : European Market for RNA Sequencing, by Product, Through 2029
  • Table 42 : European Market for RNA Sequencing for Tools and Reagents, by Type, Through 2029
  • Table 43 : European Market for RNA Sequencing, by Technology, Through 2029
  • Table 44 : European Market for RNA Sequencing, by Application, Through 2029
  • Table 45 : European Market for RNA Sequencing, by End User, Through 2029
  • Table 46 : Asia-Pacific Market for RNA Sequencing, by Product, Through 2029
  • Table 47 : Asia-Pacific Market for RNA Sequencing for Tools and Reagents, by Type, Through 2029
  • Table 48 : Asia-Pacific Market for RNA Sequencing, by Technology, Through 2029
  • Table 49 : Asia-Pacific Market for RNA Sequencing, by Application, Through 2029
  • Table 50 : Asia-Pacific Market for RNA Sequencing, by End User, Through 2029
  • Table 51 : RoW Market for RNA Sequencing, by Product, Through 2029
  • Table 52 : RoW Market for RNA Sequencing for Tools and Reagents, by Type, Through 2029
  • Table 53 : RoW Market for RNA Sequencing, by Technology, Through 2029
  • Table 54 : RoW Market for RNA Sequencing, by Application, Through 2029
  • Table 55 : RoW Market for RNA Sequencing, by End User, Through 2029
  • Table 56 : Leading Players in RNA Sequencing Market, 2023
  • Table 57 : Collaborations and Agreements in the RNA Sequencing Market, 2021-2024
  • Table 58 : New Product Launches in the RNA Sequencing Market, 2021-2024
  • Table 59 : Partnerships in the RNA Sequencing Market, 2022-2024
  • Table 60 : Expansions in the RNA Sequencing Market, 2020-2024
  • Table 61 : Mergers and Acquisitions in the RNA Sequencing Market, 2020-2024
  • Table 62 : Leading RNA Sequencing Service Providers
  • Table 63 : Key Focus Areas in ESG Metrics
  • Table 64 : Environmental Performance Initiatives in the RNA Sequencing Market
  • Table 65 : Social Performance Initiatives in RNA Sequencing Market
  • Table 66 : Governance Performance Initiatives in RNA Sequencing Market
  • Table 67 : ESG Rankings for Key Players in RNA Sequencing Market, 2024*
  • Table 68 : Acronyms Used in this Report
  • Table 69 : 10x Genomics: Company Snapshot
  • Table 70 : 10x Genomics: Financial Performance, FY 2022 and 2023
  • Table 71 : 10x Genomics: Product Portfolio
  • Table 72 : 10x Genomics: News/Key Developments, 2022 and 2023
  • Table 73 : Agilent Technologies Inc.: Company Snapshot
  • Table 74 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
  • Table 75 : Agilent Technologies Inc.: Product and Services Portfolio
  • Table 76 : Agilent Technologies Inc.: News/Key Developments, 2021-2023
  • Table 77 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
  • Table 78 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
  • Table 79 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2022-2024
  • Table 80 : Bio-Rad Laboratories Inc.: Company Snapshot
  • Table 81 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
  • Table 82 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 83 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022-2024
  • Table 84 : BGI: Company Snapshot
  • Table 85 : BGI: Product & Services Portfolio
  • Table 86 : BGI: News/Key Developments, 2024
  • Table 87 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 88 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
  • Table 89 : F. Hoffman-La Roche Ltd.: Product Portfolio
  • Table 90 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2021 and 2022
  • Table 91 : Illumina Inc.: Company Snapshot
  • Table 92 : Illumina Inc.: Financial Performance, FY 2022 and 2023
  • Table 93 : Illumina Inc.: Product Portfolio
  • Table 94 : Illumina Inc.: News/Key Developments, 2022-2024
  • Table 95 : Integrated DNA Technologies Inc.: Company Snapshot
  • Table 96 : Integrated DNA Technologies Inc.: Product & Services Portfolio
  • Table 97 : Integrated DNA Technologies Inc.: News/Key Developments, 2021-2024
  • Table 98 : Microsynth AG: Company Snapshot
  • Table 99 : Microsynth AG: Product & Services Portfolio
  • Table 100 : Microsynth AG: News/Key Developments, 2022
  • Table 101 : Oxford Nanopore Technologies plc.: Company Snapshot
  • Table 102 : Oxford Nanopore Technologies plc.: Financial Performance, FY 2022 and 2023
  • Table 103 : Oxford Nanopore Technologies plc.: Product Portfolio
  • Table 104 : Oxford Nanopore Technologies plc.: News/Key Developments, 2022-2024
  • Table 105 : QIAGEN: Company Snapshot
  • Table 106 : QIAGEN: Financial Performance, FY 2022 and 2023
  • Table 107 : QIAGEN: Product Portfolio
  • Table 108 : QIAGEN: News/Key Developments, 2022-2024
  • Table 109 : Revvity: Company Snapshot
  • Table 110 : Revvity: Financial Performance, FY 2022 and 2023
  • Table 111 : Revvity: Product Portfolio
  • Table 112 : Revvity: News/Key Developments, 2023
  • Table 113 : Standard BioTools: Company Snapshot
  • Table 114 : Standard BioTools: Financial Performance, FY 2022 and 2023
  • Table 115 : Standard BioTools: Product Portfolio
  • Table 116 : Standard BioTools: News/Key Developments, 2022-2024
  • Table 117 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 118 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
  • Table 119 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 120 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024

List of Figures

  • Summary Figure A : Global Market for RNA Sequencing, by Product, 2021-2029
  • Summary Figure B : Global Market for RNA Sequencing, by Technology, 2021-2029
  • Figure 1 : RNA-Seq Experiments for Transcriptomics
  • Figure 2 : RNA-Seq Experimental Workflow
  • Figure 3 : RNA-Seq Workflow Considerations
  • Figure 4 : Factors Related to Selecting the Right Platform for RNA-Seq
  • Figure 5 : Growth Strategy Recommendations: RNA Sequencing Market
  • Figure 6 : Market Dynamics
  • Figure 7 : Average Cost Per Genome: Y-o-Y Trend, 2011-2022
  • Figure 8 : Global Market Shares of RNA Sequencing, by Product, 2024
  • Figure 9 : Global Market for RNA Sequencing for Instruments, by Region, 2021-2029
  • Figure 10 : Global Market for RNA Sequencing for Tools and Reagents, by Region, 2021-2029
  • Figure 11 : Global Market for RNA Sequencing Sample Preparation for Tools & Reagents, by Region, 2021-2029
  • Figure 12 : Global Market for RNA Sequencing Library Preparation for Tools and Reagents, by Region, 2021-2029
  • Figure 13 : Global Market for RNA Sequencing for Software and Services, by Region, 2021-2029
  • Figure 14 : Global Market Shares of RNA Sequencing, by Technology, 2024
  • Figure 15 : Global Market for RNA Sequencing for Sequencing by Synthesis, by Region, 2021-2029
  • Figure 16 : Global Market for RNA Sequencing for Ion Torrent Semiconductor, by Region, 2021-2029
  • Figure 17 : Global Market for RNA Sequencing for Single-Molecule Real-Time Sequencing, by Region, 2021-2029
  • Figure 18 : Global Market for RNA Sequencing for Nanopore Sequencing, by Region, 2021-2029
  • Figure 19 : Major Applications of RNA Sequencing
  • Figure 20 : Global Market Shares of RNA Sequencing, by Application, 2024
  • Figure 21 : Global Market for RNA Sequencing for Expression Profiling Analysis, by Region, 2021-2029
  • Figure 22 : Global Market for RNA Sequencing for Small RNA Sequencing, by Region, 2021-2029
  • Figure 23 : Global Market for RNA Sequencing for De Novo Transcriptome Assembly, by Region, 2021-2029
  • Figure 24 : Global Market for RNA Sequencing for Variant Calling & Transcriptome Epigenetics, by Region, 2021-2029
  • Figure 25 : Global Market Shares of RNA Sequencing, by End User, 2024
  • Figure 26 : Global Market for RNA Sequencing for Academic Research Organizations, by Region, 2021-2029
  • Figure 27 : Role of RNA Sequencing in Drug Development
  • Figure 28 : Global Market for RNA Sequencing for Pharmaceutical and Biotechnology Companies, by Region, 2021-2029
  • Figure 29 : Global Market for RNA Sequencing for Clinical and Hospital Laboratories, by Region, 2021-2029
  • Figure 30 : Global Market for RNA Sequencing for Other End Users, by Region, 2021-2029
  • Figure 31 : Global Market Shares of RNA Sequencing, by Region, 2024
  • Figure 32 : North American Market for RNA Sequencing, by Product, 2021-2029
  • Figure 33 : North American Market for RNA Sequencing for Tools & Reagents, by Type, 2021-2029
  • Figure 34 : North American Market for RNA Sequencing, by Technology, 2021-2029
  • Figure 35 : North American Market for RNA Sequencing, by Application, 2021-2029
  • Figure 36 : North American Market for RNA Sequencing, by End User, 2021-2029
  • Figure 37 : European Market for RNA Sequencing, by Product, 2021-2029
  • Figure 38 : European Market for RNA Sequencing for Tools and Reagents, by Type, 2021-2029
  • Figure 39 : European Market for RNA Sequencing, by Technology, 2021-2029
  • Figure 40 : European Market for RNA Sequencing, by Application, 2021-2029
  • Figure 41 : European Market for RNA Sequencing, by End User, 2021-2029
  • Figure 42 : Growth Drivers in Asia-Pacific RNA Sequencing Market
  • Figure 43 : Asia-Pacific Market for RNA Sequencing, by Product, 2021-2029
  • Figure 44 : Asia-Pacific Market for RNA Sequencing for Tools and Reagents, by Type, 2021-2029
  • Figure 45 : Asia-Pacific Market for RNA Sequencing, by Technology, 2021-2029
  • Figure 46 : Asia-Pacific Market for RNA Sequencing, by Application, 2021-2029
  • Figure 47 : Asia-Pacific Market for RNA Sequencing, by End User, 2021-2029
  • Figure 48 : RoW Market for RNA Sequencing, by Product, 2021-2029
  • Figure 49 : RoW Market for RNA Sequencing for Tools & Reagents, by Type, 2021-2029
  • Figure 50 : RoW Market for RNA Sequencing, by Technology, 2021-2029
  • Figure 51 : RoW Market for RNA Sequencing, by Application, 2021-2029
  • Figure 52 : RoW Market for RNA Sequencing, by End User, 2021-2029
  • Figure 53 : Global Market Shares of RNA Sequencing, by Key Strategies Adopted, 2020-2024
  • Figure 54 : How a Strong ESG Proposition Benefits Businesses
  • Figure 55 : Percentage of Biotech Companies Providing ESG Disclosure, 2022
  • Figure 56 : Location of ESG Disclosure, 2022
  • Figure 57 : 10x Genomics: Revenue Shares, by Country/Region, FY 2023
  • Figure 58 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 59 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023
  • Figure 60 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 61 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
  • Figure 62 : F. Hoffman-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
  • Figure 63 : F. Hoffman-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
  • Figure 64 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 65 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2023
  • Figure 66 : Oxford Nanopore Technologies plc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 67 : Oxford Nanopore Technologies plc.: Revenue Shares, by Country/Region, FY 2023
  • Figure 68 : QIAGEN: Revenue Shares, by Business Unit, FY 2023
  • Figure 69 : QIAGEN: Revenue Shares, by Country/Region, FY 2023
  • Figure 70 : Revvity: Revenue Shares, by Business Unit, FY 2023
  • Figure 71 : Revvity: Revenue Shares, by Country/Region, FY 2023
  • Figure 72 : Standard BioTools: Revenue Shares, by Business Unit, FY 2023
  • Figure 73 : Standard BioTools: Revenue Shares, by Country/Region, FY 2023
  • Figure 74 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 75 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
目次
Product Code: BIO147B

The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2024 to 2029.

The global market for tools and reagents for RNA sequencing is expected to grow from $3.0 billion in 2024 and is projected to reach $7.4 billion by the end of 2029, at a CAGR of 19.6% during the forecast period of 2024 to 2029.

The global market for instruments for RNA sequencing is expected to grow from $645.6 million in 2024 and is projected to reach $1.5 billion by the end of 2029, at a CAGR of 18.2% during the forecast period of 2024 to 2029.

Report Scope:

This research report covers the global market for RNA sequencing. It incorporates an in-depth analysis of the RNA sequencing market, including market estimates and trends through 2029. For this analysis, the market has been segmented based on products, technologies, applications, end users and regions. In terms of geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for the base year 2023, with forecasts for 2024 through 2029.

This report also examines strategies and collaborations, discusses the regulatory landscape and analyzes macroeconomic factors when considering new technologies, the industry's growing competition and changing customer needs. It also includes various analytical frameworks, such as ESG analysis, competitive analysis and strategic recommendations, that will help companies operating within this market devise their strategic plan of action.

Report Includes:

  • 65 data tables and 57 additional tables
  • A review of the global market and technologies for RNA sequencing
  • Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the overall market for RNA sequencing, and corresponding market share analysis by product, technology, application, end-user and region
  • Discussion of recent RNA sequencing approaches such as next-generation sequencing (NGS) technology, single nucleotide polymorphism (SNP) discovery, RNA editing, and Sanger sequencing technology
  • Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
  • Analysis of the regulatory landscape and macroeconomic factors impacting the market
  • Coverage of the most recent approvals, recalls, safety alerts and clinical trials
  • Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes
  • Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
  • Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., and Qiagen

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • Technology Background
  • Transcriptomics Technologies
  • RNA Sequencing for Transcriptomics
  • RNA-Seq Experimental Workflow
  • RNA-Seq Workflow Considerations
  • Steps to Select the Right Platform for RNA Sequencing
  • Regulatory Landscape
  • Growth Strategy Recommendations

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Rapid Advances in Data Analysis Capabilities
  • Favorable Funding Scenario for Genomics and Biomedical Research Activities
  • Decline in the Prices of Genome Sequencing
  • Growing Prevalence of Cancer Generating Demand for Personalized Treatments
  • Market Restraints
  • Lack of Data Standardization
  • Cost vs. Coverage Challenges
  • Market Opportunities
  • Harnessing Blockchain and Cloud Computing Technologies
  • Technological Advances in RNA Isolation and Extraction Processes

Chapter 4 Emerging Technologies and Developments

  • Single-Cell RNA Sequencing
  • Other Emerging Single-Cell Technologies

Chapter 5 Market Segmentation Analysis

  • Key Market Trends
  • Segmentation Breakdown
  • Global Market for RNA Sequencing by Product
  • Instruments
  • Tools and Reagents
  • Software and Services
  • Global Market for RNA Sequencing by Technology
  • Sequencing by Synthesis
  • Ion Torrent Semiconductor Sequencing
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Global Market for RNA Sequencing by Application
  • Expression Profiling Analysis
  • Small RNA Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling and Transcriptome Epigenetics
  • Global Market for RNA Sequencing by End User
  • Academic Research Organizations
  • Pharmaceutical and Biotechnology Companies
  • Clinical and Hospital Laboratories
  • Other End Users
  • Geographic Breakdown
  • Global RNA Sequencing Market by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Overview
  • Ranking of Leading Market Players
  • Key Strategies Adopted by Players
  • Collaborations and Agreements
  • New Product Launches
  • Partnerships
  • Expansions
  • Mergers and Acquisitions
  • The Role of CROs in RNA Sequencing Data Generation
  • Leading RNA Sequencing Service Providers

Chapter 7 Sustainability in RNA Sequencing Market: ESG Perspective

  • Introduction to ESG
  • ESG Performance in the Market
  • ESG Practices in the RNA Sequencing Industry
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks from BCC Research

Chapter 8 Appendix

  • Methodology
  • References
  • Acronyms
  • Company Profiles
  • 10X GENOMICS
  • AGILENT TECHNOLOGIES INC.
  • BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
  • BIO-RAD LABORATORIES INC.
  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA INC.
  • INTEGRATED DNA TECHNOLOGIES INC.
  • MICROSYNTH AG
  • OXFORD NANOPORE TECHNOLOGIES PLC.
  • QIAGEN
  • REVVITY
  • STANDARD BIOTOOLS
  • THERMO FISHER SCIENTIFIC INC.